Psychosocial Benefits of Exercise in Endometrial Cancer Survivors
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
To determine if weekly exercise compared to stretching has an effect on fatigue, depression, and anxiety in endometrial cancer survivors.
| Condition | Intervention | Phase |
|---|---|---|
|
Endometrial Cancer |
Behavioral: 150 weekly minutes walking Behavioral: 75 weekly minutes walking Behavioral: Stretching/Flexibility exercise |
Phase 1 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Supportive Care |
| Official Title: | Psychosocial Benefits of Exercise in Endometrial Cancer Survivors |
- fatigue [ Time Frame: Change from baseline at 12 weeks ] [ Designated as safety issue: No ]13-item multi-dimensional fatigue scale [i.e. Fatigue Symptom Inventory (FACT-F)]
- Depression and Anxiety [ Time Frame: Change from baseline at 8 weeks ] [ Designated as safety issue: No ]14 item Hospital Anxiety and Depression Scale (PROMIS)
- Depression and Anxiety [ Time Frame: Change in baseline at 12 weeks ] [ Designated as safety issue: No ]14 item Hospital Anxiety and Depression Scale (PROMIS)
- Task self-efficacy [ Time Frame: Change in baseline at 8 weeks ] [ Designated as safety issue: No ]4 item scale for chronic disease patients
- Task self-efficacy [ Time Frame: Change in baseline at 12 weeks ] [ Designated as safety issue: No ]4 item scale for chronic disease patients
- Quality of Life [ Time Frame: Change in baseline at 8 weeks ] [ Designated as safety issue: No ]Functional Assessment of Cancer Therapy-Endometrial and the Satisfaction With Life Scale
- Quality of Life [ Time Frame: Change in baseline at 12 weeks ] [ Designated as safety issue: No ]Functional Assessment of Cancer Therapy-Endometrial and the Satisfaction With Life Scale
- Body Mass Index (BMI) [ Time Frame: Change in baseline at 8 weeks ] [ Designated as safety issue: No ]BMI calculated with weight and height
- Body Mass Index (BMI) [ Time Frame: Change in baseline at 12 weeks ] [ Designated as safety issue: No ]BMI calculated with weight and height
- Body Composition [ Time Frame: Change in baseline at 8 weeks ] [ Designated as safety issue: No ]Bioelectrical Impedance
- Body Composition [ Time Frame: Change in baseline at 12 weeks ] [ Designated as safety issue: No ]Bioelectrical Impedance
- Waist and Hip circumferences [ Time Frame: Change in baseline at 8 weeks ] [ Designated as safety issue: No ]the average of three measures of waist and hip (each) using a tape measure
- Waist and Hip circumferences [ Time Frame: Change in baseline at 12 weeks ] [ Designated as safety issue: No ]the average of three measures of waist and hip (each) using a tape measure
- fitness [ Time Frame: Change in baseline at 8 weeks ] [ Designated as safety issue: No ]submaximal fitness test
- fitness [ Time Frame: Change in baseline at 12 weeks ] [ Designated as safety issue: No ]submaximal fitness test
- muscle strength [ Time Frame: Change in baseline at 8 weeks ] [ Designated as safety issue: No ]back/leg dynamometer and hand grip dynamometer
- muscle strength [ Time Frame: Change in baseline at 12 weeks ] [ Designated as safety issue: No ]back/leg dynamometer and hand grip dynamometer
- feasibility [ Time Frame: one year ] [ Designated as safety issue: Yes ]Number of patients recruited, Number of patients who complete the walking intervention, Number of adverse events reported, and Number of patients who complete the study
- demographic, lifestyle, and medical covariates [ Time Frame: one year ] [ Designated as safety issue: No ]self-administered survey
| Enrollment: | 2 |
| Study Start Date: | July 2011 |
| Estimated Study Completion Date: | September 2013 |
| Estimated Primary Completion Date: | June 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 75 weekly minutes walking
12-week physical activity intervention group with a goal of 75 minutes of moderate intensity exercise (walking) per week
|
Behavioral: 75 weekly minutes walking
12 week physical activity intervention group with a goal of 75 minutes of moderate intensity exercise (walking) per week on a treadmill while supervised by exercise specialists who are certified by ACSM and trained and monitored for quality control and safety
Other Name: moderate intensity aerobic walking
|
|
Experimental: 150 weekly minutes walking
12 week physical activity intervention group with a goal of 150 minutes of moderate intensity exercise (walking) per week
|
Behavioral: 150 weekly minutes walking
12 week physical activity intervention group with a goal of 150 minutes of moderate intensity exercise (walking) per week on a treadmill while supervised by exercise specialists who are certified by ACSM and trained and monitored for quality control and safety
Other Name: moderate intensity aerobic walking
|
|
Active Comparator: Stretching and Flexibility exercise
Stretching/Flexibility exercise
|
Behavioral: Stretching/Flexibility exercise
12 week stretching intervention group with a goal of 3 sessions per week while supervised by exercise specialists who are certified by ACSM and trained and monitored for quality control and safety
Other Name: stretching exercise
|
Detailed Description:
Endometrial cancer is the most prevalent gynecologic cancer in women. Because of its excellent 5 year survival rate of 83%, addressing longer term cancer effects in this group is an important aspect of cancer survivor care. Unfortunately, women with a history of endometrial cancer may report persistent levels of fatigue, depression, and anxiety that are, on average, higher than those of healthy, gynecologic out-patients. Physical activity is one potential approach to reducing these symptoms, but little is known about the effects of physical activity in endometrial cancer survivors specifically. Furthermore, current evidence is insufficient to make recommendations regarding the optimal exercise amount, type, and duration for improving fatigue, depression, or anxiety after a cancer diagnosis (any cancer type).
This pilot, randomized trial is unique in its focus on endometrial cancer survivors, a previously understudied population with a large potential for benefiting from regular physical activity. Two separate walking intervention groups will work with an exercise specialist three times a week to walk for either 75 minutes (group 1) or 150 minutes (group 2) weekly. The participants will start out slowly and then gradually increase to the particular group goal of 75 or 150 minutes. The stretching exercise group will work with an exercise specialist doing stretching/flexibility exercises three times a week starting with 15 seconds and then gradually increasing to 30 seconds of holding the stretch.
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- 1) Female, 18 to 70 years of age with history of Stage I, II, or III endometrial cancer diagnosis occurring at least 6 months prior to study enrollment,
- 2) if chemotherapy or radiation therapy was received, patient must be ≥ 4 weeks post final primary treatment administration,
- 3) if patient has undergone surgical procedure, must be ≥ 8 weeks post-procedure or cleared by surgeon for moderate intensity walking,
- 4) English speaking,
- 5) medical clearance for participation provided by primary care physician or oncologist,
- 6) average fatigue over the past week of ≥3 on a 1 to 10 Likert scale or worrying thoughts ≥ a lot of the time or enjoy the things they used to a little/ not at all.
Exclusion Criteria:
- 1) metastatic or recurrent endometrial cancer,
- 2) inability to ambulate without assistance,
- 3) unstable angina,
- 4) New York Heart Association class II, III, or IV congestive heart failure,
- 5) uncontrolled asthma,
- 6) having been told by a physician to only do exercise prescribed by a physician,
- 7) dementia or organic brain syndrome,
- 8) schizophrenia or active psychosis,
- 9) participating, on average, in more than 20 minutes of physical activity on two or more days per week during the past six months,
- 10) anticipates undergoing elective surgery during the duration of the intervention which would interfere with the intervention participation,
- 11) does not live or work less than 50 miles from the study site,
- 12) lack of transportation to the study site,
- 13) plans to move residence out of the local area during the study duration,
- 14) plans to travel out of the local area for more than a week during the intervention,
- 15) contraindication to participation in physical activity,
- 16) non-compliant with sleep apnea treatments.
Contacts and Locations| United States, Illinois | |
| Southern Illinois University School of Medicine | |
| Springfield, Illinois, United States, 62702 | |
| Principal Investigator: | Laura Q. Rogers, MD, MPH | Southern Illinois University School of Medicine |
More Information
Additional Information:
Publications:
| Responsible Party: | Laura Rogers, MD, MPH, Professor, Southern Illinois University |
| ClinicalTrials.gov Identifier: | NCT01401829 History of Changes |
| Other Study ID Numbers: | ROG-SIU-11-004 |
| Study First Received: | July 21, 2011 |
| Last Updated: | February 20, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Southern Illinois University:
|
endometrial cancer aerobic walking stretching/flexibility exercises quality of life |
Additional relevant MeSH terms:
|
Endometrial Neoplasms Sarcoma, Endometrial Stromal Adenoma Uterine Neoplasms Genital Neoplasms, Female Urogenital Neoplasms Neoplasms by Site Neoplasms |
Uterine Diseases Genital Diseases, Female Neoplasms, Complex and Mixed Neoplasms by Histologic Type Sarcoma Neoplasms, Connective and Soft Tissue Endometrial Stromal Tumors Neoplasms, Glandular and Epithelial |
ClinicalTrials.gov processed this record on June 18, 2013